Butalbital, Aspirin, Caffeine and Codeine Phosphate (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Butalbital, Aspirin, Caffeine and Codeine Phosphate drug offered from Actavis Pharma, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
SUBSTANCE NAME: | CODEINE PHOSPHATE; BUTALBITAL; CAFFEINE; ASPIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2006-10-26 |
END MARKETING DATE: | 0000-00-00 |
Butalbital, Aspirin, Caffeine and Codeine Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Butalbital, Aspirin, Caffeine and Codeine Phosphate from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 30; 50; 40; 325(mg/1; mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2006-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-3546_5ffcd5c0-9fd7-467e-a947-5b6617289442 |
PRODUCT NDC: | 0591-3546 |
APPLICATION NUMBER: | NDA019429 |
Other CODEINE PHOSPHATE; BUTALBITAL; CAFFEINE; ASPIRIN Pharmaceutical Manufacturers / Labelers: